Elevated glycated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial

T A Chowdhury1, S S Lasker

  • 1Department of Medicine, Queen Elizabeth Hospital, Birmingham, UK.

Insights

Elevated glycated haemoglobin (HbA1c) levels are a significant risk factor for death after acute myocardial infarction, even in non-diabetic individuals. This finding highlights HbA1c as a crucial marker for short-term mortality risk.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Diabetes mellitus is linked to higher mortality rates post-acute myocardial infarction (AMI).
  • Elevated glycated haemoglobin (HbA1c) in diabetic patients correlates with increased AMI mortality.
  • Mild HbA1c elevations can indicate impaired glucose tolerance.

Purpose of the Study:

  • To investigate the impact of HbA1c on AMI outcomes in non-diabetic patients.
  • To identify HbA1c as a potential risk marker in this population.

Main Methods:

  • Study included 253 non-diabetic patients experiencing AMI.
  • Univariate and logistic regression analyses were performed.
  • Risk factors for one-year mortality were assessed, including HbA1c, glucose, cholesterol, and smoking status.

Main Results:

  • A total of 46 patients died within one year.
  • Univariate analysis identified smoking, glucose, cholesterol, and HbA1c as risk factors for death.
  • Logistic regression confirmed HbA1c as an independent risk factor for mortality.
  • The highest HbA1c quartile was more prevalent in the non-surviving group (over one-third) compared to survivors (one-fifth).

Conclusions:

  • Elevated HbA1c serves as a significant risk marker for short-term mortality following acute myocardial infarction in individuals without diabetes.
  • HbA1c monitoring may be valuable for risk stratification in non-diabetic AMI patients.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...